ARCHIVES

In Brief: NCI To Move Todaro’s Lab to FCR; Cinnamyl Anthranilate Was Carciogenic In Bioassay

This article is from The Cancer Letter archive.

Vol. 06 No. 13 | March 28, 1980

Download PDF Visit The Full Archive

Related Articles

Institutions Fail To Credit NIH when Patenting discoveries, HHS Says

July 15, 1994

Phase III Xtandi Trial Meets Primary Endpoints Of Progression-Free and Overall Survival

November 29, 2013

Komen Foundation Shifts Emphasis To Underserved

May 7, 1993

Top NCI Officials Pledge No Further Consolidation of Clinical Trials System

December 5, 2014

FDA Approves Imaging System To Detect Cervical Pre-Cancer

March 31, 2006

Also in this 8-page issue: Bush nominates McClellan to head CMS.

February 27, 2004